Literature DB >> 408320

In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.

B E Malmvall, J E Brorsson, J Johnsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408320     DOI: 10.1093/jac/3.4.374

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  31 in total

1.  Increase in bronchopulmonary infection due to branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; S Capewell; M J Croughan; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

2.  Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.

Authors:  E E Stobberingh; H J van Eck; A W Houben; C P van Boven
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors:  R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Purification and properties of a beta-lactamase produced by Branhamella catarrhalis.

Authors:  E Yokota; T Fujii; K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

5.  Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.

Authors:  I Luman; R W Wilson; R J Wallace; D R Nash
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

6.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 7.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

8.  Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

Authors:  H J Bootsma; H van Dijk; J Verhoef; A Fleer; F R Mooi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

10.  Branhamella keratitis.

Authors:  K R Wilhelmus; J Peacock; D J Coster
Journal:  Br J Ophthalmol       Date:  1980-12       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.